e-Table 1.
Baseline demographic and treatment characteristics of ParticiPants and non-participants
| N |
SSE vs Neither |
PSE vs Neither |
Both vs Neither |
P-value |
||||
|---|---|---|---|---|---|---|---|---|
| aRRR* | 95% CI | aRRR | 95% CI | aRRR | 95% CI | |||
| Number of times saw regular PCP in last 2 years | ||||||||
| 0-2 | 297 | 1.00 | REF | 1.00 | REF | 1.00 | REF | 0.55 |
| 3-6 | 326 | 1.29 | (0.78,2.14) | 1.05 | (0.59,1.85) | 1.10 | (0.63,1.89) | |
| 7+ | 105 | 0.64 | (0.28,1.42) | 0.64 | (0.26,1.6) | 1.16 | (0.54,2.47) | |
| Saw dermatologist in last 2 years | ||||||||
| No | 512 | 1.00 | REF | 1.00 | REF | 1.00 | REF | < 0.001 |
| Yes | 215 | 1.14 | (0.6,2.17) | 31.79 | (15.43,65.5) | 24.91 | (12.99,47.8) | |
| Asked HCP/Derm to check whole body in last 12 months | ||||||||
| No | 583 | 1.00 | REF | 1.00 | REF | 1.00 | REF | < 0.001 |
| Yes | 141 | 2.28 | (0.19,27.07) | 1331.33 | (234.24,7566.66) | 2370.27 | (405.84,13843.3) | |
| Prepare list of concerns for routine health care visit | ||||||||
| Always/Very often | 192 | 1.00 | REF | 1.00 | REF | 1.00 | REF | < 0.001 |
| Fairly often/Sometimes | 317 | 0.79 | (0.45,1.39) | 0.81 | (0.42,1.55) | 0.80 | (0.45,1.42) | |
| Almost never/Never | 219 | 0.38 | (0.19,0.73) | 0.57 | (0.27,1.21) | 0.12 | (0.05,0.31) | |
| Ask about screening during routine health care visit | ||||||||
| Always/Very often | 92 | 1.00 | REF | 1.00 | REF | 1.00 | REF | < 0.001 |
| Fairly often/Sometimes | 259 | 0.45 | (0.21,0.96) | 0.55 | (0.22,1.37) | 0.30 | (0.15,0.62) | |
| Almost never/Never | 377 | 0.20 | (0.09,0.42) | 0.40 | (0.16,0.98) | 0.06 | (0.03,0.13) | |
| Heard about "ABCDE" rule for melanoma? | ||||||||
| No | 578 | 1.00 | REF | 1.00 | REF | 1.00 | REF | < 0.001 |
| Yes | 145 | 1.03 | (0.53,2.01) | 2.59 | (1.32,5.1) | 4.72 | (2.57,8.66) | |
*
Adjusted for sex, education, age (years), race/ethnicity, skin type, age at diagnosis, diagnosis, chemotherapy (yes/no), Highest CTCAE Grade Chronic Condition, maximum radiotherapy dose, patient activation.